A detailed history of High Tower Advisors, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 3,829 shares of ITCI stock, worth $319,415. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,829
Holding current value
$319,415
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.99 - $80.84 $260,333 - $309,536
3,829 New
3,829 $279,000
Q1 2024

May 06, 2024

SELL
$64.37 - $75.65 $1,737 - $2,042
-27 Reduced 0.77%
3,474 $240,000
Q4 2023

Feb 12, 2024

BUY
$46.37 - $73.65 $162,341 - $257,848
3,501 New
3,501 $250,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.